Thomas Fritz-Hansen

Thomas Fritz-Hansen

Auto-generated profile, based on publicly available information

Thomas Fritz-Hansen

Department of Cardiology, Herlev & Gentofte Hospital, University of Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2016 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
TBTor Biering-Sørensen
Tor Biering-Sørensen
FOFlemming Javier Olsen
Flemming Javier Olsen
KSKatrine Storm
Katrine Storm
TFThomas Fritz-Hansen
Thomas Fritz-Hansen
NONiels Thue Olsen
Niels Thue Olsen
NRNiels Risum
Niels Risum
Only 30% of patients receiving an implantable cardioverter defibrillator (ICD) for primary prevention receive appropriately therapy. We sought to investigate the value of tissue Doppler imaging (TDI) to predict ventricular tachycardia (VT), ventricular fibrillation (VF), and cardiovascular mortality (CVD) in patients with primary prevention ICD. In total, 151 ICD patients meeting primary prevention criteria and with no history of ventricular arrhythmias were included. All participants were examined by conventional 2D echocardiography and TDI echocardiography. Longitudinal systolic ( s ′), early diastolic ( e ′), and late diastolic ( a ′) myocardial velocities were measured using TDI at six mitral annular sites and averaged to provide global estimates. Forty patients experienced the combined endpoint of VT, VF, or CVD during a median follow-up of 2.3 years. Left ventricular ejection fraction, global longitudinal strain, E / e ′, global s ′, and global e ′ were not significantly different in patients who developed VT/VF/CVD compared with those who did not. In contrast, global a ′ was significantly lower in patients with an unfavourable outcome compared with those without (4.8 ± 2.0 vs. 5.7 ± 1.8 cm/s, P = 0.020). Global a ′ remained an independent predictor of VT/VF/CVD after multivariable adjustment for age, gender, β-blocker therapy, and deceleration time (HR = 1.25 [1.02, 1.54], P = 0.032). Regional analysis revealed that a depressed a ′ in the inferior wall drives the predictive capability of a ′. Late diastolic velocity by TDI seems to be a superior echocardiographic predictor of VT/VF/CVD in ischaemic cardiomyopathy. Additionally, impaired late diastolic velocity in the inferior myocardial wall seems to be a paramount marker of future VT/VF/CVD.

1 November 2018 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Open access
ILIngrid Josefine Lundorff
Ingrid Josefine Lundorff
MSMorten Sengeløv
Morten Sengeløv
PJPeter Godsk Jørgensen
Peter Godsk Jørgensen
SPSune Pedersen
Sune Pedersen
DMDaniel Modin
Daniel Modin
TBTor Biering-Sørensen
Tor Biering-Sørensen
Background: Previous studies found that global longitudinal strain is a superior predictor of mortality in male patients with heart failure with reduced ejection fraction (EF). This does not apply to women. Our aim was to investigate sex-specific differences in cardiac function and identify echocardiographic predictors of mortality in women with heart failure with reduced EF. Methods and Results: Echocardiographic examinations were retrieved from 968 patients with heart failure with reduced EF (26.7% women). Images were analyzed offline, and the end point was all-cause mortality. During follow-up (median: 41 months) 163 patients (16.8 %) died. Women had significantly higher left ventricular (LV) EF (27.1% versus 25.4%, P =0.004), global longitudinal strain (−9.9% versus −8.9%, P <0.001), and global circumferential strain (−10.9% versus −9.7%, P <0.001). Moreover, women displayed higher E/e′ (14.4 versus 13.0, P =0.004), LV diastolic elastance (1.16 versus 0.75, P <0.001), and lower e′ (6.2 cm/s versus 6.9 cm/s, P <0.001). In women, tricuspid annular plane systolic excursion and LV isovolumetric relaxation time were significant predictors of outcome after multivariable adjustment (tricuspid annular plane systolic excursion: hazard ratio, 1.11; 95% CI, 1.04–1.18; P =0.003 per 1 mm decrease; isovolumetric relaxation time: hazard ratio, 1.07; 95% CI, 1.03–1.10; P =0.001 per 5 ms decrease). LVEF and global longitudinal strain were significant predictors in men (LVEF: hazard ratio, 0.94; 95% CI, 0.90–0.99; P =0.014 per 1% increase; global longitudinal strain: hazard ratio, 1.20; 95% CI, 1.04–1.38; P =0.013 per 1% decrease). Conclusions: Tricuspid annular plane systolic excursion and LV isovolumetric relaxation time provide prognostic information in women but not in men. Hence, in women with heart failure with reduced EF, right ventricular function, and LV diastolic function seem paramount in predicting mortality, whereas LV systolic function is more important in men.

2 October 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PJPeter Godsk Jørgensen
Peter Godsk Jørgensen
MJMagnus Thorsten Jensen
Magnus Thorsten Jensen
TBTor Biering-Sørensen
Tor Biering-Sørensen
RMRasmus Mogelvang
Rasmus Mogelvang
TFThomas Fritz‐Hansen
Thomas Fritz‐Hansen
JJJan Skov Jensen
Jan Skov Jensen
Background: Type 2 diabetes mellitus is closely associated with metabolic risk factors that all contribute to impairment of the left ventricle. The implications of having type 2 diabetes mellitus with well‐controlled metabolic risk factors compared to an increasing burden of uncontrolled metabolic risk factors on left ventricular structure and function are not known. Methods and Results: We compared patients with type 2 diabetes mellitus (n=751) with different degrees of uncontrolled metabolic risk factors present with a control group of individuals without present uncontrolled metabolic risk factors as recommended by the World Health Organization (n=80). In patients with well‐controlled metabolic risk factors, only diastolic but neither structural nor systolic measures were impaired compared to the control group: the (early diastolic mitral inflow velocity)/(atrial diastolic mitral inflow velocity) ratio (median 0.94 [interquartile range 0.80, 1.08] versus 1.11 [0.85, 1.38], P <0.001), lateral early diastolic myocardial velocity at the level of the mitral annulus (mean 9.6 m/s [SD 2.5] versus 10.8 [3.5], P <0.001) and lateral (early diastolic mitral inflow velocity)/(early diastolic myocardial velocity at the level of the mitral annulus) (7.7 [6.5, 10.2] versus 6.3 [4.9, 7.8], P <0.001). With an increasing burden of uncontrolled metabolic risk factors, there were increased left ventricular mass index and wall thicknesses and impaired systolic function measured as global longitudinal strain: control group −15.9 (2.0); 0 uncontrolled risk factors −15.3 (2.4); 1 to 2 −14.6 (2.8); and ≥3 −14.0 (2.8), P <0.001. Within the diabetes mellitus group, there were uni‐ and multivariable associations of left ventricular measures and systolic blood pressure, body mass index, hemoglobin A 1c , and HDL ‐cholesterol. Conclusions: In patients with type 2 diabetes mellitus, having well‐controlled metabolic risk factors was associated with only left ventricular diastolic impairment but not with either structural or even subtle measures of systolic function. Increasing burden of uncontrolled metabolic risk factors was associated with structural and functional impairments.

11 December 2017 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
PBPhilip Brainin
Philip Brainin
SHSune Haahr-Pedersen
Sune Haahr-Pedersen
MSMorten Sengeløv
Morten Sengeløv
FOFlemming Javier Olsen
Flemming Javier Olsen
TFThomas Fritz-Hansen
Thomas Fritz-Hansen
TBTor Biering-Sørensen
Tor Biering-Sørensen

1 June 2021 in IJC Heart & Vasculature
Verified
Journal Article
Open access
PBPhilip Brainin
Philip Brainin
SLSøren Lindberg
Søren Lindberg
FOFlemming Javier Olsen
Flemming Javier Olsen
SPSune Pedersen
Sune Pedersen
AIAllan Iversen
Allan Iversen
TBTor Biering-Sørensen
Tor Biering-Sørensen
Early systolic lengthening (ESL), a paradoxical stretch of myocardial fibers, has been linked to loss of myocardial viability and contractile dysfunction. We assessed the long-term prognostic potential of ESL in coronary artery bypass graft (CABG) patients. We retrospectively included patients (n = 709; mean age 68 years; 85% men) who underwent speckle tracking echocardiography (median 15 days) prior to CABG. Endpoints were cardiovascular death (CVD) and all-cause mortality. We assessed amplitude of ESL (%), defined as peak positive strain, and duration of ESL (ms), determined as time from Q-wave on the ECG to peak positive strain. We applied Cox models adjusted for clinical risk assessed as EuroSCORE II. During median follow-up of 3.8 years [IQR 2.7–4.9 years], 45 (6%) experienced CVD and 80 (11%) died. In survival analyses adjusted for EuroSCORE II, each 1% increase in amplitude of ESL was associated with CVD (HR 1.35 [95%CI 1.09–1.68], P = 0.006) and all-cause mortality (HR 1.29 [95%CI 1.08–1.54], P = 0.004). Similar findings applied to duration of ESL (per 10ms increase) and CVD (HR 1.12 [95%CI 1.02–1.23], P = 0.016) and all-cause mortality (HR 1.09 [95%CI 1.01––1.17], P = 0.031). The prognostic value of ESL amplitude was modified by sex (P interaction < 0.05), such that the prognostic value was greater in women for both endpoints. When adding ESL duration to EuroSCORE II, the net reclassification index improved significantly for both CVD and all-cause mortality. Assessment of ESL provides independent and incremental prognostic information in addition to the EuroSCORE II for CVD and all-cause mortality in CABG patients.

1 April 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
FOFlemming Javier Olsen
Flemming Javier Olsen
SLSøren Lindberg
Søren Lindberg
TFThomas Fritz-Hansen
Thomas Fritz-Hansen
DMDaniel Modin
Daniel Modin
SPSune Pedersen
Sune Pedersen
TBTor Biering-Sørensen
Tor Biering-Sørensen